Major medical societies unveil first-ever life course framework for women's heart health

Four major medical societies — the American Heart Association, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine — have jointly released a first-of-its-kind, three-part clinical framework published in Circulation. The series ties cardiovascular disease (CVD) risk to female-specific life stages, from adolescence to menopause, aiming to replace fragmented, one-size-fits-all care with a personalized, life course approach.

The framework recognizes that biological milestones unique to women — including irregular periods linked to polycystic ovarian metabolic syndrome, adverse pregnancy outcomes like preeclampsia, and early menopause — serve as important CV risk enhancers. It also highlights the mind-body connection, noting that hormonal fluctuations during pregnancy, postpartum, and menopause can amplify anxiety and depression, further elevating CVD risk.

Key Takeaways:

• The presidential advisory defines female life stages and explains why a sex-specific CVD lens is needed
• The scientific statement provides clinicians with explicit guidance on assessing hormonal, psychosocial, and CV health at each life stage
• The scientific advisory outlines four pillars of comprehensive women's heart centers: interdisciplinary care, education & training, research, and community engagement

Why it matters: CVD is the leading cause of death in both women and men, yet women remain underrepresented in research and their unique risk factors are routinely overlooked. This framework gives clinicians a concrete playbook to identify risk earlier, act sooner, and deliver more holistic care across a woman's entire lifespan.